Molecular targeting in radiotherapy of lung cancer

被引：22
作者：
Baumann, M
Krause, M
Zips, D
Petersen, C
Dittmann, K
Dörr, W
Rodemann, HP
机构：
[1] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Radiat Oncol, D-01307 Dresden, Germany
[2] Tech Univ Dresden, Med Fac Carl Gustav Carus, Expt Ctr, D-01307 Dresden, Germany
[3] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, D-01307 Dresden, Germany
[4] Univ Tubingen, Dept Radiat Oncol, Sect Radiobiol & Mol Environm Res, Tubingen, Germany
来源：
LUNG CANCER | 2004年 / 45卷
关键词：
radiotherapy; tumour response; normal tissue reactions; molecular targeting; EGFR; COX-2; angiogenesis; KGF; TGF-beta; BBI; translational research; tumour growth delay; local tumour control;
D O I：
10.1016/j.lungcan.2004.07.975
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Molecular targeting is a promising option to increase the radiation response of tumours and to decrease normal tissue reactions, i.e. to achieve therapeutic gain. Molecular targeting substances in themselves are not curative while radiation is a highly efficient cytotoxic agent, with local recurrences often occurring from only few surviving clonogenic cells. High-dose radiotherapy therefore offers optimal conditions to evaluate the potential of specific biology-driven drugs for oncology. This review summarises the current status of preclinical and clinical research on combined radiation with examples of molecular targeting substances relevant for the treatment of NSCLC (EGFR, COX-2, VEGFR, KGF, TGF-beta, BBI). (C) 2004 Elsevier Science Ltd.
引用
收藏
页码：S187 / S197
页数：11
相关论文
共 120 条
  • [11] Baumann M, 2000, FRONT RADIAT THER ON, V34, P80
  • [12] BAUMANN M, 2002, ONKOLOGE, V8, P448
  • [13] BEGG AC, 1987, RODENT TUMOR MODELS, P114
  • [14] Bentzen SM, 2000, INT J RADIAT BIOL, V76, P453, DOI 10.1080/095530000138448
  • [15] BENTZEN SM, 2002, BASIC CLIN RADIOBIOL, P134
  • [16] BENTZEN SM, 2002, BASIC CLIN RADIOBIOL, P94
  • [17] Ongoing and future trials of biologic therapies in lung cancer
    Bunn, PA
    Shepherd, FA
    Sandler, A
    Le Chevalier, T
    Belani, CP
    Kosmidis, PA
    Scagliotti, GV
    Giaccone, G
    [J]. LUNG CANCER, 2003, 41 : S175 - S186
  • [18] Molecular and cellular basis of radiation fibrosis
    Burger, A
    Löffler, H
    Bamberg, M
    Rodemann, HP
    [J]. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1998, 73 (04) : 401 - 408
  • [19] Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: A rational advance?
    Choy, H
    Milas, L
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (19): : 1440 - 1452
  • [20] Ciardiello F, 2001, CLIN CANCER RES, V7, P2958
12345678910